Actin-Pathway Research
Studied in experimental models examining thymosin-beta-4-related actin regulation and cytoskeletal signaling.
Overview
TB-500 is a synthetic fragment of Thymosin Beta-4, studied for its role in actin regulation and its relevance to tissue repair and recovery research.
Suria's TB-500 is manufactured for high-purity peptide research, with analytical documentation to be made available through Suria's Batch Documentation system, giving researchers a consistent, well-documented starting point for cytoskeletal and recovery-pathway studies.
Research Use Only. Not for human or veterinary use.
Specifications
Certificate of Analysis
Certificate of Analysis
Checking certificate…
Other documentation: Batch Documentation.
Research Highlights
Studied in experimental models examining thymosin-beta-4-related actin regulation and cytoskeletal signaling.
Used in laboratory research examining cell migration, cytoskeletal organization, and related signaling pathways.
Studied as a thymosin-beta-4-related research material in cytoskeletal and cell-response models.
Consistent, well-documented starting material for cytoskeletal and cell-signaling research.
Storage
Store at −20°C, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the laboratory's established handling window.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation